2025.04.23 Loos Group launches Denmark’s largest precision health cohort Nearly half of all adults in Denmark are affected by obesity, diabetes, or cardiovascular disease. Yet, there remains a significant gap in understanding the individual factors that contribute to the development of these conditions.
Research Facilities Technology platforms have been established to advance basic research questions and to empower scientists to accelerate their discoveries and innovations.
Education opportunities The Center’s mission is to provide the highest standards in the training of future scientists by developing transferable skills and career opportunities.
We need a better understanding of what drives us to eat In this interview, Assistant Professor Nathalie Krauth talks about her scientific background and journey to publishing a recent paper in Nature Neuroscience.
Newly discovered ‘molecular fingerprints’ could transform diabetes treatment and diagnosis Unprecedented insights into insulin resistance could pave the way for better treatments and earlier detection of type 2 diabetes.
Researchers map 7,000-year-old genetic mutation that protects against HIV Modern HIV medicine is based on a common genetic mutation. Now, researchers have traced where and when the mutation arose.
CBMR spinout Ousia Pharma raises three-digit million amount to develop their groundbreaking obesity treatment The spinout builds on a discovery by the Clemmensen Group that NMDA receptor antagonism holds promise for sustained weight loss, which was later published in Nature.